{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:03:55Z","timestamp":1784063035910,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kidnie"},{"DOI":"10.13039\/501100004329","name":"Slovenian Research Agency","doi-asserted-by":"crossref","award":["P3-0458"],"award-info":[{"award-number":["P3-0458"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019719","name":"Chiesi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"DOI":"10.1007\/s00467-026-07433-0","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:32:02Z","timestamp":1784053922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarkers related to immunosuppression in pediatric kidney transplantation"],"prefix":"10.1007","author":[{"given":"Harm","family":"den Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thurid","family":"Ahlenstiel-Grunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Novljan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Busutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Eibensteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"D\u00fczova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth A. M.","family":"Cornelissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia H. M.","family":"Bouts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke H. M.","family":"Vrieling-Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0105-5560","authenticated-orcid":false,"given":"Huib","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"7433_CR1","doi-asserted-by":"crossref","unstructured":"T\u00f6nshoff B, Melk A, H\u00f6cker B (2023) Immunosuppression in pediatric kidney\u00a0transplantation. In: Schaefer F, Greenbaum LA (eds) Pediatric kidney disease.\u00a0Springer International Publishing, Cham, 1849\u20131886","DOI":"10.1007\/978-3-031-11665-0_67"},{"key":"7433_CR2","doi-asserted-by":"crossref","unstructured":"Francis A, Johnson DW, Craig JC, Wong G (2017) Incidence and Predictors of\u00a0Cancer Following Kidney Transplantation in Childhood. Am J Transplant\u00a017:2650\u20132658","DOI":"10.1111\/ajt.14289"},{"key":"7433_CR3","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.ekir.2024.08.025","volume":"9","author":"M Baghai Arassi","year":"2024","unstructured":"Baghai Arassi M, Feisst M, Krupka K, Awan A, Benetti E, Duzova A, Guzzo I, Kim JJ, Kranz B, Litwin M, Oh J, Buscher A, Pape L, Peruzzi L, Shenoy M, Testa S, Weber LT, Zieg J, Hocker B, Fichtner A, Tonshoff B, Cooperative European Pediatric Renal Transplant Initiative Research Network (2024) Age-related differences in rejection rates, infections, and tacrolimus exposure in pediatric kidney transplant recipients in the CERTAIN Registry. Kidney Int Rep 9:3265\u20133277","journal-title":"Kidney Int Rep"},{"key":"7433_CR4","doi-asserted-by":"crossref","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman\u00a0RE (2003) Developmental pharmacology--drug disposition, action, and therapy\u00a0in infants and children. N Engl J Med 349:1157\u20131167","DOI":"10.1056\/NEJMra035092"},{"key":"7433_CR5","unstructured":"Rosenbaum SE (2016) Basic pharmacokinetics and pharmacodynamics: an integrated textbook and computer simulations, 2nd ed. Wiley, New York"},{"key":"7433_CR6","doi-asserted-by":"crossref","unstructured":"Langhoff E, Ladefoged J (1987) The impact of high lymphocyte sensitivity to\u00a0glucocorticoids on kidney graft survival in patients treated with azathioprine and\u00a0cyclosporine. Transplantation 43:380\u2013384","DOI":"10.1097\/00007890-198703000-00012"},{"key":"7433_CR7","unstructured":"(2025) What is a good biomarker? OLINK. https:\/\/7074596.fs1.hubspotusercontent-na1.net\/hubfs\/7074596\/6.Whitepapers\/1594-Olink-White%20Paper%20What%20is%20a%20good%20biomarker%202025.pdf Accesed 5\u201312\u20132026"},{"key":"7433_CR8","doi-asserted-by":"crossref","unstructured":"(2010) Biomarkers on a roll. Nat Biotechnol 28:431\u2013431","DOI":"10.1038\/nbt0510-431"},{"key":"7433_CR9","doi-asserted-by":"crossref","unstructured":"Holland R (2016) What makes a good biomarker? Advances in Precision\u00a0Medicine 1:4\u201311","DOI":"10.18063\/apm.v1i1.17"},{"key":"7433_CR10","doi-asserted-by":"crossref","unstructured":"Weber LT (2015) Therapeutic drug monitoring in pediatric renal transplantation.\u00a0Pediatr Nephrol 30:253\u2013265","DOI":"10.1007\/s00467-014-2813-8"},{"key":"7433_CR11","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnewald A, Ahlenstiel-Grunow T, Arslan Z, Battelino N, Rachisan A-LB, Bouts A, Busutti M, Cornelissen E, de Jong H, Dudley J, D\u00fczova A, Eibensteiner F, Fichtner A, Fomina S, Gonzalez ML, Gulhan B, Grabitz C, Hogan J, H\u00f6cker B, Jeruschke S, Kanzelmeyer N, Kim JJ, Korst U, Labbadia R, Litwin M, Marks S, Melk A, Novljan G, Obrycki L, Oh J, Pape N, Pasini A, Patry C, Pohl M, Preka E, Prytula A, Rieger S, Schiffer M, Schild R, Seeman T, Stojanovic J, Testa S, T\u00f6nshoff B, Torres DD, Weber LT, Nothacker M, Pape L (2026) Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation. Transplantation 10.1097\/TP.0000000000005772","DOI":"10.1097\/TP.0000000000005772"},{"key":"7433_CR12","doi-asserted-by":"crossref","unstructured":"van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A,\u00a0Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tonshoff B, Keown\u00a0P, Campbell S, Mamelok RD (2008) Comparing mycophenolate mofetil\u00a0regimens for de novo renal transplant recipients: the fixed-dose concentration regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation 86:1043\u20131051","DOI":"10.1097\/TP.0b013e318186f98a"},{"key":"7433_CR13","doi-asserted-by":"crossref","unstructured":"Ahlenstiel-Grunow T, Liu X, Schild R, Oh J, Taylan C, Weber LT, Staude H,\u00a0Verboom M, Schroder C, Sabau R, Grosshennig A, Pape L (2021) Steering\u00a0transplant immunosuppression by measuring virus-specific t cell levels: the\u00a0randomized, controlled IVIST trial. J Am Soc Nephrol 32:502\u2013516","DOI":"10.1681\/ASN.2020050645"},{"key":"7433_CR14","doi-asserted-by":"crossref","unstructured":"Andrews LM, Hesselink DA, van Gelder T, Koch BCP, Cornelissen EAM,\u00a0Bruggemann RJM, van Schaik RHN, de Wildt SN, Cransberg K, de Winter BCM\u00a0(2018) A population pharmacokinetic model to predict the individual starting\u00a0dose of tacrolimus following pediatric renal transplantation. Clin\u00a0Pharmacokinet 57:475\u2013489","DOI":"10.1007\/s40262-017-0567-8"},{"key":"7433_CR15","doi-asserted-by":"crossref","unstructured":"Grenda R, Watson A, Trompeter R, Tonshoff B, Jaray J, Fitzpatrick M, Murer L,\u00a0Vondrak K, Maxwell H, Van Damme-Lombaerts R, Loirat C, Mor E, Cochat P,\u00a0Milford DV, Brown M, Webb NJA (2010) A randomized trial to assess the impact\u00a0of early steroid withdrawal on growth in pediatric renal transplantation: the\u00a0TWIST study. Am J Transplant 10:828\u2013836","DOI":"10.1111\/j.1600-6143.2010.03047.x"},{"key":"7433_CR16","doi-asserted-by":"crossref","unstructured":"Elens L, Bouamar R, Hesselink DA, Haufroid V, van der Heiden IP, van Gelder\u00a0T, van Schaik RH (2011) A new functional CYP3A4 intron 6 polymorphism\u00a0significantly affects tacrolimus pharmacokinetics in kidney transplant recipients.\u00a0Clin Chem 57:1574\u20131583","DOI":"10.1373\/clinchem.2011.165613"},{"key":"7433_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00871","volume":"10","author":"E Abdel-Kahaar","year":"2019","unstructured":"Abdel-Kahaar E, Winter S, Tremmel R, Schaeffeler E, Olbricht CJ, Wieland E, Schwab M, Shipkova M, Jaeger SU (2019) The impact of CYP3A4*22 on tacrolimus pharmacokinetics and outcome in clinical practice at a single kidney transplant center. Front Genet 10:871","journal-title":"Front Genet"},{"key":"7433_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115706","volume":"168","author":"X Diaz-Villamarin","year":"2023","unstructured":"Diaz-Villamarin X, Fernandez-Varon E, Rojas Romero MC, Callejas-Rubio JL, Cabeza-Barrera J, Rodriguez-Nogales A, Galvez J, Moron R (2023) Azathioprine dose tailoring based on pharmacogenetic information: insights of clinical implementation. Biomed Pharmacother 168:115706","journal-title":"Biomed Pharmacother"},{"key":"7433_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jval.2013.10.007","volume":"17","author":"AJ Thompson","year":"2014","unstructured":"Thompson AJ, Newman WG, Elliott RA, Roberts SA, Tricker K, Payne K (2014) The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine. Value Health 17:22\u201333","journal-title":"Value Health"},{"key":"7433_CR20","doi-asserted-by":"crossref","unstructured":"Wiebe C, Nickerson P (2016) Strategic use of epitope matching to improve\u00a0outcomes. Transplantation 100:2048\u20132052","DOI":"10.1097\/TP.0000000000001284"},{"key":"7433_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/petr.12815","volume":"20","author":"JY Kausman","year":"2016","unstructured":"Kausman JY, Walker AM, Cantwell LS, Quinlan C, Sypek MP, Ierino FL (2016) Application of an epitope-based allocation system in pediatric kidney transplantation. Pediatr Transplant 20:931\u2013938","journal-title":"Pediatr Transplant"},{"key":"7433_CR22","doi-asserted-by":"crossref","unstructured":"Philogene MC, Amin A, Zhou S, Charnaya O, Vega R, Desai N, Neu AM, Pruette\u00a0CS (2020) Eplet mismatch analysis and allograft outcome across racially\u00a0diverse groups in a pediatric transplant cohort: a single-center analysis. Pediatr\u00a0Nephrol 35:83-94","DOI":"10.1007\/s00467-019-04344-1"},{"key":"7433_CR23","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/ajt.12478","volume":"13","author":"C Wiebe","year":"2013","unstructured":"Wiebe C, Pochinco D, Blydt-Hansen TD, Ho J, Birk PE, Karpinski M, Goldberg A, Storsley LJ, Gibson IW, Rush DN, Nickerson PW (2013) Class II HLA epitope matching-a strategy to minimize de novo donor-specific antibody development and improve outcomes. Am J Transplant 13:3114\u20133122","journal-title":"Am J Transplant"},{"key":"7433_CR24","doi-asserted-by":"crossref","unstructured":"Snanoudj R, Kamar N, Cassuto E, Caillard S, Metzger M, Merville P, Thierry A,\u00a0Jollet I, Grimbert P, Anglicheau D, Hazzan M, Choukroun G, Hurault De Ligny\u00a0B, Janbon B, Vuiblet V, Devys A, Le Meur Y, Delahousse M, Morelon E, Bailly\u00a0E, Girerd S, Amokrane K, Legendre C, Hertig A, Rondeau E, Taupin JL (2019)\u00a0Epitope load identifies kidney transplant recipients at risk of allosensitization\u00a0following minimization of immunosuppression. Kidney Int 95:1471\u20131485","DOI":"10.1016\/j.kint.2018.12.029"},{"key":"7433_CR25","doi-asserted-by":"crossref","unstructured":"de Weerd AE, Fatly ZA, Boer-Verschragen M, Kal-van Gestel JA, Roelen DL,\u00a0Dieterich M, Betjes MGH (2022) Tacrolimus monotherapy is safe in\u00a0immunologically low-risk kidney transplant recipients: a randomized-controlled pilot study. Transpl Int 35:10839","DOI":"10.3389\/ti.2022.10839"},{"key":"7433_CR26","doi-asserted-by":"crossref","unstructured":"Puliyanda DP, Swinford R, Pizzo H, Garrison J, De Golovine AM, Jordan SC\u00a0(2021) Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft\u00a0rejection in pediatric kidney transplants. Pediatr Transplant 25:e13850","DOI":"10.1111\/petr.13850"},{"key":"7433_CR27","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2016091034","volume":"28","author":"RD Bloom","year":"2017","unstructured":"Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC,\u00a0Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators (2017) Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 28:2221\u20132232","journal-title":"J Am Soc Nephrol"},{"key":"7433_CR28","doi-asserted-by":"crossref","unstructured":"Chandar J, Sigurjonsdottir V, Defreitas M, Gavcovich T, Zhou M, Glehn-Ponsirenas R, Burke G, 3rd (2025) Donor-derived cell-free DNA testing in\u00a0pediatric kidney transplant recipients: indications and clinical utility. Pediatr\u00a0Nephrol 40:2669\u20132678","DOI":"10.1007\/s00467-025-06770-w"},{"key":"7433_CR29","doi-asserted-by":"crossref","unstructured":"Akifova A, Budde K, Amann K, Buettner-Herold M, Choi M, Oellerich M, Beck\u00a0J, Bornemann-Kolatzki K, Schutz E, Bachmann F, Halleck F, von\u00a0Hoerschelmann E, Koch N, Schrezenmeier E, Seelow E, Waiser J, Zukunft B,\u00a0Eckardt KU, Halbritter J, Kettritz R, Del Moral CL, Lachmann N, Stauch D,\u00a0Niemann M, Schmidt D, Halloran PF, Osmanodja B (2025) Donor-derived cell-free\u00a0DNA monitoring for early diagnosis of antibody-mediated rejection after\u00a0kidney transplantation: a randomized trial. Nephrol Dial Transplant 40:1384\u20131395\u00a0","DOI":"10.1093\/ndt\/gfae282"},{"key":"7433_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14582","volume":"28","author":"D Ranch","year":"2024","unstructured":"Ranch D, Fei M, Kincade E, Piburn K, Hitchman K, Klein K (2024) Utilization of donor-derived cell-free DNA in pediatric kidney transplant recipients: a single center study. Pediatr Transplant 28:e14582","journal-title":"Pediatr Transplant"},{"key":"7433_CR31","doi-asserted-by":"crossref","unstructured":"Mayer KA, Omic H, Weseslindtner L, Doberer K, Reindl-Schwaighofer R, Viard\u00a0T, Tillgren A, Haindl S, Casas S, Eskandary F, Heinzel A, Kozakowski N, Kikic\u00a0Z, Bohmig GA, Eder M (2022) Levels of donor-derived cell-free DNA and\u00a0chemokines in BK polyomavirus-associated nephropathy. Clin Transplant\u00a036:e14785","DOI":"10.1111\/ctr.14785"},{"key":"7433_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.814517","volume":"8","author":"W Nie","year":"2021","unstructured":"Nie W, Su X, Liu L, Li J, Fu Q, Li X, Wu C, Wang J, Deng R, Chen E, Yang S, Li S, Zhang H, Wang C (2021) Dynamics of donor-derived cell-free DNA at the early phase after pediatric kidney transplantation: a prospective cohort study. Front Med 8:814517","journal-title":"Front Med"},{"key":"7433_CR33","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2215\/CJN.03840322","volume":"17","author":"R Dandamudi","year":"2022","unstructured":"Dandamudi R, Gu H, Goss CW, Walther L, Dharnidharka VR (2022) Longitudinal evaluation of donor-derived cellfree DNA in pediatric kidney transplantation. Clin J Am Soc Nephrol 17:1646\u20131655","journal-title":"Clin J Am Soc Nephrol"},{"key":"7433_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1031894","volume":"13","author":"M Oellerich","year":"2022","unstructured":"Oellerich M, Budde K, Osmanodja B, Bornemann-Kolatzki K, Beck J, Schutz E, Walson PD (2022) Donor-derived cell-free DNA as a diagnostic tool in transplantation. Front Genet 13:1031894","journal-title":"Front Genet"},{"key":"7433_CR35","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1111\/ajt.13803","volume":"16","author":"T Vanhove","year":"2016","unstructured":"Vanhove T, Vermeulen T, Annaert P, Lerut E, Kuypers DRJ (2016) High intrapatient variability of tacrolimus concentrations predicts accelerated progression of chronic histologic lesions in renal recipients. Am J Transplant 16:2954\u20132963","journal-title":"Am J Transplant"},{"key":"7433_CR36","doi-asserted-by":"crossref","unstructured":"Sellares J, de Freitas DG, Mengel M, Reeve J, Einecke G, Sis B, Hidalgo LG,\u00a0Famulski K, Matas A, Halloran PF (2012) Understanding the causes of kidney\u00a0transplant failure: the dominant role of antibody-mediated rejection and\u00a0nonadherence. Am J Transplant 12:388\u2013399","DOI":"10.1111\/j.1600-6143.2011.03840.x"},{"key":"7433_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/petr.12247","volume":"18","author":"D Athavale","year":"2014","unstructured":"Athavale D, Worthington J, Webb NJ, Roberts D, Martin S, Shenoy M (2014) Pediatric kidney recipients may benefit from monitoring for donor-specific antibodies. Pediatr Transplant 18:258\u2013265","journal-title":"Pediatr Transplant"},{"key":"7433_CR38","doi-asserted-by":"crossref","unstructured":"van den Broek DAJ, Meziyerh S, Budde K, Lefaucheur C, Cozzi E, Bertrand D,\u00a0Lopez Del Moral C, Dorling A, Emonds MP, Naesens M, de Vries APJ,\u00a0Monitoring EWGSD (2023) The clinical utility of post-transplant monitoring of\u00a0donor-specific antibodies in stable renal transplant recipients: a consensus\u00a0report with guideline statements for clinical practice. Transpl Int 36:11321","DOI":"10.3389\/ti.2023.11321"},{"key":"7433_CR39","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13511","volume":"23","author":"AM Strommen","year":"2019","unstructured":"Strommen AM, Moss MC, Goebel J, Bock M (2019) Donor-specific antibodies in a pediatric kidney transplant population-prevalence and association with antiproliferative drug dosing. Pediatr Transplant 23:e13511","journal-title":"Pediatr Transplant"},{"key":"7433_CR40","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.ajt.2025.07.2486","volume":"25","author":"MH Pearl","year":"2025","unstructured":"Pearl MH, Chen L, Grogan T, Nikfarjam N, Grimm PC, Fan C, Garro R, Tsai-Chambers E, Kirk AD, Ettenger R, Reed EF (2025) Antibodies to angiotensin II type 1 receptor and endothelin type A receptor are associated with cytokine production enriched for type 2 immune response and antibody production in pediatric kidney transplant recipients. Am J Transplant 25:2329\u20132344","journal-title":"Am J Transplant"},{"key":"7433_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/ti.2025.14463","volume":"38","author":"F Schmidt","year":"2025","unstructured":"Schmidt F, Verboom M, Hallensleben M, Braumann A, Drube J, Brunkhorst L, Haffner D, Melk A, Kanzelmeyer N (2025) Development of non-HLA antibodies and their association with antibody-mediated rejection in pediatric kidney transplant recipients. Transpl Int 38:14463","journal-title":"Transpl Int"},{"key":"7433_CR42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41591-022-01725-2","volume":"28","author":"R Carapito","year":"2022","unstructured":"Carapito R, Aouadi I, Verniquet M, Untrau M, Pichot A, Beaudrey T, Bassand X, Meyer S, Faucher L, Posson J, Morlon A, Kotova I, Delbos F, Walencik A, Aarnink A, Kennel A, Suberbielle C, Taupin JL, Matern BM, Spierings E, Congy-Jolivet N, Essaydi A, Perrin P, Blancher A, Charron D, Cereb N, Maumy-Bertrand M, Bertrand F, Garrigue V, Pernin V, Weekers L, Naesens M, Kamar N, Legendre C, Glotz D, Caillard S, Ladriere M, Giral M, Anglicheau D, Susal C, Bahram S (2022) The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation. Nat Med 28:989\u2013998","journal-title":"Nat Med"},{"key":"7433_CR43","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/ajt.13684","volume":"16","author":"M Sester","year":"2016","unstructured":"Sester M, Leboeuf C, Schmidt T, Hirsch HH (2016) The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation. Am J Transplant 16:1697\u20131706","journal-title":"Am J Transplant"},{"key":"7433_CR44","doi-asserted-by":"crossref","unstructured":"Sester M, Leboeuf C, Schmidt T, Hirsch HH (2016) The \"ABC\" of Virus-Specific\u00a0T Cell Immunity in Solid Organ Transplantation. Am J Transplant 16:1697\u20131706","DOI":"10.1111\/ajt.13684"},{"key":"7433_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1337367","volume":"11","author":"M Reineke","year":"2024","unstructured":"Reineke M, Morath C, Speer C, Rudek M, Bundschuh C, Klein JAF, Mahler CF, Kalble F, Nusshag C, Beimler J, Zeier M, Bartenschlager R, Schnitzler P, Benning L (2024) Dynamics of torque teno virus load in kidney transplant recipients with indication biopsy and therapeutic modifications of immunosuppression. Front Med 11:1337367","journal-title":"Front Med"},{"key":"7433_CR46","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1097\/TP.0000000000004153","volume":"106","author":"P Jaksch","year":"2022","unstructured":"Jaksch P, Gorzer I, Puchhammer-Stockl E, Bond G (2022) Integrated immunologic monitoring in solid organ transplantation: the road toward torque teno virus-guided immunosuppression. Transplantation 106:1940\u20131951","journal-title":"Transplantation"},{"key":"7433_CR47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00467-020-04606-3","volume":"36","author":"P Uhl","year":"2021","unstructured":"Uhl P, Heilos A, Bond G, Meyer E, Bohm M, Puchhammer-Stockl E, Arbeiter K, Muller-Sacherer T, Csaicsich D, Aufricht C, Rusai K (2021) Torque teno viral load reflects immunosuppression in paediatric kidney-transplanted patients-a pilot study. Pediatr Nephrol 36:153\u2013162","journal-title":"Pediatr Nephrol"},{"key":"7433_CR48","doi-asserted-by":"crossref","unstructured":"Kelly E, Awan A, Sweeney C, Wildes D, De Gascun C, Hassan J, Riordan M\u00a0(2024) Torque teno virus loads as a marker of immunosuppression in pediatric\u00a0kidney transplant recipients. Pediatr Transplant 28:e14857","DOI":"10.1111\/petr.14857"},{"key":"7433_CR49","doi-asserted-by":"crossref","unstructured":"Schiemann M, Puchhammer-Stockl E, Eskandary F, Kohlbeck P, Rasoul-Rockenschaub S, Heilos A, Kozakowski N, Gorzer I, Kikic Z, Herkner H, Bohmig\u00a0GA, Bond G (2017) Torque teno virus load-inverse association with antibody-mediated rejection after kidney transplantation. Transplantation 101:360\u2013367","DOI":"10.1097\/TP.0000000000001455"},{"key":"7433_CR50","doi-asserted-by":"crossref","unstructured":"Doberer K, Haupenthal F, Nackenhorst M, Bauernfeind F, Dermuth F,\u00a0Eigenschink M, Schiemann M, Klager J, Gorzer I, Eskandary F, Reindl-Schwaighofer R, Kikic Z, Bohmig G, Strassl R, Regele H, Puchhammer-Stockl\u00a0E, Bond G (2021) Torque teno virus load is associated with subclinical\u00a0alloreactivity in kdney transplant recipients: a prospective observational\u00a0trial. Transplantation 105:2112\u20132118","DOI":"10.1097\/TP.0000000000003619"},{"key":"7433_CR51","doi-asserted-by":"crossref","unstructured":"Strassl R, Doberer K, Rasoul-Rockenschaub S, Herkner H, Gorzer I, Klager JP,\u00a0Schmidt R, Haslacher H, Schiemann M, Eskandary FA, Kikic Z, Reindl-Schwaighofer R, Puchhammer-Stockl E, Bohmig GA, Bond G (2019) Torque\u00a0teno virus for risk stratification of acute biopsy-proven alloreactivity in kidney\u00a0transplant recipients. J Infect Dis 219:1934\u20131939","DOI":"10.1093\/infdis\/jiz039"},{"key":"7433_CR52","doi-asserted-by":"crossref","unstructured":"Doberer K, Schiemann M, Strassl R, Haupenthal F, Dermuth F, Gorzer I,\u00a0Eskandary F, Reindl-Schwaighofer R, Kikic Z, Puchhammer-Stockl E, Bohmig\u00a0GA, Bond G (2020) Torque teno virus for risk stratification of graft rejection and\u00a0infection in kidney transplant recipients-A prospective observational trial. Am J\u00a0Transplant 20:2081-2090","DOI":"10.1111\/ajt.15810"},{"key":"7433_CR53","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ajt.15145","volume":"19","author":"M Fernandez-Ruiz","year":"2019","unstructured":"Fernandez-Ruiz M, Albert E, Gimenez E, Ruiz-Merlo T, Parra P, Lopez-Medrano F, San Juan R, Polanco N, Andres A, Navarro D, Aguado JM (2019) Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation. Am J Transplant 19:1139\u20131149","journal-title":"Am J Transplant"},{"key":"7433_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jinf.2019.05.010","volume":"79","author":"M Solis","year":"2019","unstructured":"Solis M, Velay A, Gantner P, Bausson J, Filipputtu A, Freitag R, Moulin B, Caillard S, Fafi-Kremer S (2019) Torquetenovirus viremia for early prediction of graft rejection after kidney transplantation. J Infect 79:56\u201360","journal-title":"J Infect"},{"key":"7433_CR55","doi-asserted-by":"crossref","unstructured":"van Rijn AL, Wunderink HF, Sidorov IA, de Brouwer CS, Kroes AC, Putter H, de\u00a0Vries AP, Rotmans JI, Feltkamp MC (2021) Torque teno virus loads after kidney\u00a0transplantation predict allograft rejection but not viral infection. J Clin Virol\u00a0140:104871","DOI":"10.1016\/j.jcv.2021.104871"},{"key":"7433_CR56","doi-asserted-by":"crossref","unstructured":"Eibensteiner F, Messner I, Uhl P, Bond G, Puchhammer-Stoeckl E, Mueller-Sacherer T, Aufricht C, Rusai K (2024) The association of Torque Teno viral load\u00a0with CMV and BKV infection in pediatric and adolescent kidney transplant\u00a0patients. J Clin Virol 172:105673","DOI":"10.1016\/j.jcv.2024.105673"},{"key":"7433_CR57","doi-asserted-by":"crossref","unstructured":"Eldar-Yedidia Y, Ben-Shalom E, Hillel M, Belostotsky R, Megged O, Freier-Dror\u00a0Y, Frishberg Y, Schlesinger Y (2022) Association of post-transplantation\u00a0anellovirus viral load with kidney transplant rejection in children. Pediatr\u00a0Nephrol 37:1905\u20131914","DOI":"10.1007\/s00467-021-05336-w"},{"key":"7433_CR58","doi-asserted-by":"crossref","unstructured":"Gorzer I, Haupenthal F, Maggi F, Gelas F, Kulifaj D, Brossault L, Puchhammer-Stockl E, Bond G (2023) Validation of plasma Torque Teno viral load applying a\u00a0CE-certified PCR for risk stratification of rejection and infection post kidney\u00a0transplantation. J Clin Virol 158:105348","DOI":"10.1016\/j.jcv.2022.105348"},{"key":"7433_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13063-023-07216-0","volume":"24","author":"F Haupenthal","year":"2023","unstructured":"Haupenthal F, Rahn J, Maggi F, Gelas F, Bourgeois P, Hugo C, Jilma B, Bohmig GA, Herkner H, Wolzt M, Doberer K, Vossen M, Focosi D, Neuwirt H, Banas M, Banas B, Budde K, Viklicky O, Malvezzi P, Rostaing L, Rotmans JI, Bakker SJL, Eller K, Cejka D, Perez AM, Rodriguez-Arias D, Konig F, Bond G,\u00a0TTVguideTX consortium partners\u00a0(2023) A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT. Trials 24:213","journal-title":"Trials"},{"key":"7433_CR60","doi-asserted-by":"crossref","unstructured":"Gottlieb J, Reuss A, Mayer K, Weide K, Schade-Brittinger C, Hoyer S, Jaksch\u00a0P (2021) Viral load-guided immunosuppression after lung transplantation\u00a0(VIGILung)-study protocol for a randomized controlled trial. Trials 22:48","DOI":"10.1186\/s13063-020-04985-w"},{"key":"7433_CR61","doi-asserted-by":"crossref","unstructured":"Francis DM, Dumble LJ, Bowes L, Clunie GJ, Macdonald IM (1988) Adverse\u00a0influence of recipient lymphoid resistance to in vitro immunosuppression on the\u00a0outcome of kidney transplants. Transplantation 46:853\u2013857","DOI":"10.1097\/00007890-198812000-00012"},{"key":"7433_CR62","doi-asserted-by":"crossref","unstructured":"Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, Kozaki M (1994)\u00a0Clinical significance of glucocorticoid pharmacodynamics assessed by\u00a0antilymphocyte action in kidney transplantation. Marked difference between\u00a0prednisolone and methylprednisolone. Transplantation 57:1341\u20131348","DOI":"10.1097\/00007890-199405150-00010"},{"key":"7433_CR63","doi-asserted-by":"crossref","unstructured":"Langhoff E, Ladefoged J, Jakobsen BK, Platz P, Ryder LP, Svejgaard A,\u00a0Thaysen JH (1986) Recipient lymphocyte sensitivity to methylprednisolone\u00a0affects cadaver kidney graft survival. Lancet 1:1296\u20131297","DOI":"10.1016\/S0140-6736(86)91220-1"},{"key":"7433_CR64","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.2042-7158.1991.tb03538.x","volume":"43","author":"T Hirano","year":"1991","unstructured":"Hirano T, Oka K, Sakurai E, Tamaki T, Kozaki M (1991) Impaired prednisolone sensitivities of the endocrine system and peripheral-blood lymphocytes are closely related to clinical incidence in renal transplantation. J Pharm Pharmacol 43:569\u2013573","journal-title":"J Pharm Pharmacol"},{"key":"7433_CR65","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.clinthera.2014.06.019","volume":"36","author":"G Muhetaer","year":"2014","unstructured":"Muhetaer G, Takeuchi H, Unezaki S, Kawachi S, Iwamoto H, Nakamura Y, Shimazu M, Sugiyama K, Hirano T (2014) Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation. Clin Ther 36:1264\u20131272","journal-title":"Clin Ther"},{"key":"7433_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2710.2009.01036.x","volume":"34","author":"K Sugiyama","year":"2009","unstructured":"Sugiyama K, Isogai K, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M, Takahashi K, Saito N, Hirano T (2009) Cyclosporine pharmacological efficacy estimated by lymphocyte immunosuppressant sensitivity test before and after renal transplantation. J Clin Pharm Ther 34:539\u2013545","journal-title":"J Clin Pharm Ther"},{"key":"7433_CR67","doi-asserted-by":"crossref","unstructured":"Sugiyama K, Isogai K, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M,\u00a0Takahashi K, Hirano T (2012) Clinical significance of the pharmacological\u00a0efficacy of tacrolimus estimated by the Lymphocyte Immunosuppressant\u00a0Sensitivity Test (LIST) before and after renal transplantation. Cell Med 3:81-88","DOI":"10.3727\/215517912X639360"},{"key":"7433_CR68","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3109\/08923970903490478","volume":"32","author":"K Sugiyama","year":"2010","unstructured":"Sugiyama K, Isogai K, Horisawa S, Toyama A, Satoh H, Saito K, Nakagawa Y, Tasaki M, Takahashi K, Hirano T (2010) The pharmacological efficacy of mycophenolic acid before and after renal transplantation as estimated by the lymphocyte immunosuppressant sensitivity test (LIST). Immunopharmacol Immunotoxicol 32:430\u2013436","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"7433_CR69","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0041-1345(97)01172-X","volume":"30","author":"H Takeuchi","year":"1998","unstructured":"Takeuchi H, Hirano T, Oka K, Mizumoto K, Akashi T, Sakurai E, Degawa T, Uchiyama M, Kozaki K, Matsuno N, Nagao T, Kozaki M (1998) Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation. Transplant Proc 30:36\u201339","journal-title":"Transplant Proc"},{"key":"7433_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.618202","volume":"11","author":"JM Portoles","year":"2020","unstructured":"Portoles JM, Jimenez C, Janeiro D, Lopez-Oliva MO, Ortega-Carrion A, Blanquez D, Arribas L, Gomez C, Diez T, Pascual J, Portero I (2020) The immunobiogram, a novel in vitro assay to evaluate treatment resistance in patients receiving immunosuppressive therapy. Front Immunol 11:618202","journal-title":"Front Immunol"},{"key":"7433_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101711","volume":"75","author":"J Pascual","year":"2022","unstructured":"Pascual J, Jimenez C, Krajewska M, Seron D, Kotton CN, Portoles J, Witzke O, Sorensen SS, Andres A, Crespo M, Paz-Artal E, Diez T, Ortega A, Portero I (2022) The immunobiogram, a novel in vitro diagnostic test to measure the pharmacodynamic response to immunosuppressive therapy in kidney transplant patients. Transpl Immunol 75:101711","journal-title":"Transpl Immunol"},{"key":"7433_CR72","doi-asserted-by":"crossref","unstructured":"Crespo M, Silva HT, Diekmann F, Facundo C, Ruiz J, Mazuecos A, Rostaing L, Sancho A, Jimenez C, Sommerer C, Polanco N, Lorant T, Moreno M, Budde K, Portoles J, Nunez A, Ortega A, Diez T, Portero I, Pascual J (2025) Pretransplant response to immunosuppressants measured with immunobiogram predicts first-year rejection in kidney transplant recipients. Am J Transplant 25:S174","DOI":"10.1016\/j.ajt.2025.07.382"},{"key":"7433_CR73","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1600-6143.2004.00617.x","volume":"4","author":"P Glander","year":"2004","unstructured":"Glander P, Hambach P, Braun KP, Fritsche L, Giessing M, Mai I, Einecke G, Waiser J, Neumayer HH, Budde K (2004) Pre-transplant inosine monophosphate dehydrogenase activity is associated with clinical outcome after renal transplantation. Am J Transplant 4:2045\u20132051","journal-title":"Am J Transplant"},{"key":"7433_CR74","doi-asserted-by":"crossref","unstructured":"Fukuda T, Goebel J, Thogersen H, Maseck D, Cox S, Logan B, Sherbotie J,\u00a0Seikaly M, Vinks AA (2011) Inosine monophosphate dehydrogenase (IMPDH)\u00a0activity as a pharmacodynamic biomarker of mycophenolic acid effects in\u00a0pediatric kidney transplant recipients. J Clin Pharmacol 51:309\u2013320","DOI":"10.1177\/0091270010368542"},{"key":"7433_CR75","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/j.1399-3046.2010.01354.x","volume":"14","author":"H Billing","year":"2010","unstructured":"Billing H, Giese T, Sommerer C, Zeier M, Feneberg R, Meuer S, Tonshoff B (2010) Pharmacodynamic monitoring of cyclosporine A by NFAT-regulated gene expression and the relationship with infectious complications in pediatric renal transplant recipients. Pediatr Transplant 14:844\u2013851","journal-title":"Pediatr Transplant"},{"key":"7433_CR76","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/j.1600-6143.2011.03680.x","volume":"11","author":"JA Jackson","year":"2011","unstructured":"Jackson JA, Kim EJ, Begley B, Cheeseman J, Harden T, Perez SD, Thomas S, Warshaw B, Kirk AD (2011) Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant 11:2228\u20132234","journal-title":"Am J Transplant"},{"key":"7433_CR77","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14718","volume":"28","author":"E Barrett-Chan","year":"2024","unstructured":"Barrett-Chan E, Wang L, Bone J, Thachil A, Vytlingam K, Blydt-Hansen T (2024) Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10\/creatinine testing in pediatric kidney transplant recipients. Pediatr Transplant 28:e14718","journal-title":"Pediatr Transplant"},{"key":"7433_CR78","doi-asserted-by":"crossref","unstructured":"Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J (2015) Elevated urinary\u00a0CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection\u00a0in pediatric renal transplantation. Transplantation 99:797\u2013804","DOI":"10.1097\/TP.0000000000000419"},{"key":"7433_CR79","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/ajt.16336","volume":"21","author":"TD Blydt-Hansen","year":"2021","unstructured":"Blydt-Hansen TD, Sharma A, Gibson IW, Wiebe C, Sharma AP, Langlois V, Teoh CW, Rush D, Nickerson P, Wishart D, Ho J (2021) Validity and utility of urinary CXCL10\/Cr immune monitoring in pediatric kidney transplant recipients. Am J Transplant 21:1545\u20131555","journal-title":"Am J Transplant"},{"key":"7433_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70299","volume":"39","author":"AA Souza","year":"2025","unstructured":"Souza AA, Hesselink DA, Maas C, Stubbs AP, Clahsen-van Groningen M, Baan CC, Klaveren DV, Boer K (2025) A comprehensive assessment of plasma CXCL9 and CXCL10 in improving clinical prediction models for kidney allograft rejection. Clin Transplant 39:e70299","journal-title":"Clin Transplant"},{"key":"7433_CR81","doi-asserted-by":"crossref","unstructured":"Macioniene E, Simanavicius M, Vitkauskaite M, Vickiene A, Stauce R,\u00a0Vinikovas A, Miglinas M (2024) Urinary chemokines CXCL9 and CXCL10 are\u00a0non-invasive biomarkers of kidney transplant rejection. Ann Transplant\u00a029:e944762","DOI":"10.12659\/AOT.944762"},{"key":"7433_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70390-x","volume":"14","author":"C Tinel","year":"2024","unstructured":"Tinel C, Sauvaget V, Aouni L, Lamarthee B, Terzi F, Legendre C, Rabant M, Anglicheau D (2024) Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation. Sci Rep 14:20357","journal-title":"Sci Rep"},{"key":"7433_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/cc6089","volume":"11","author":"M Zappitelli","year":"2007","unstructured":"Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL (2007) Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11:R84","journal-title":"Crit Care"},{"key":"7433_CR84","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/ndt\/gfad226","volume":"39","author":"JS Swolinsky","year":"2024","unstructured":"Swolinsky JS, Hinz RM, Markus CE, Singer E, Bachmann F, Halleck F, Kron S, Naik MG, Schmidt D, Obermeier M, Gebert P, Rauch G, Kropf S, Haase M, Budde K, Eckardt KU, Westhoff TH, Schmidt-Ott KM (2024) Plasma NGAL levels in stable kidney transplant recipients and the risk of allograft loss. Nephrol Dial Transplant 39:483\u2013495","journal-title":"Nephrol Dial Transplant"},{"key":"7433_CR85","doi-asserted-by":"crossref","unstructured":"de Jong H, Terpstra A, Meys K, Zwiers A, Sloots C, Cornelissen E, Bouts A, De Rijke Y, Van Rosmalen J, Cransberg K (2021) Abstracts of the 53rd ESPN Annual Meeting, Amsterdam, The Netherlands, September 2021. Pediatr Nephrol 36:3285\u20133491","DOI":"10.1007\/s00467-021-05210-9"},{"key":"7433_CR86","unstructured":"Qurashi S, Ghamdi G, Jaradat M, Tamim H, Aljumah A, Tamimi W, Al Dawood\u00a0A, Binsalih S, Al Sayyari A (2014) Urinary neutrophil gelatinase-associated\u00a0lipocalin and the occurrence of delayed graft function after kidney transplant.\u00a0Exp Clin Transplant 12:396\u2013400"},{"key":"7433_CR87","doi-asserted-by":"crossref","unstructured":"de Rooij ENM, van Duijl TT, Hoogeveen EK, Romijn F, Dekker FW, van Kooten\u00a0C, Cobbaert CM, de Fijter JW (2025) Urinary NGAL Outperforms (99m)Tc-MAG3 renography in predicting DCD kidney graft function. Transpl Int\u00a038:13818","DOI":"10.3389\/ti.2025.13818"},{"key":"7433_CR88","doi-asserted-by":"crossref","unstructured":"Cantaluppi V, Dellepiane S, Tamagnone M, Medica D, Figliolini F, Messina M,\u00a0Manzione AM, Gai M, Tognarelli G, Ranghino A, Dolla C, Ferrario S, Tetta C,\u00a0Segoloni GP, Camussi G, Biancone L (2015) Neutrophil gelatinase associated\u00a0lipocalin is an early and accurate biomarker of graft function and tissue\u00a0regeneration in kidney transplantation from extended criteria donors. PLoS\u00a0One 10:e0129279","DOI":"10.1371\/journal.pone.0129279"},{"key":"7433_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209708","volume":"13","author":"W Chancharoenthana","year":"2018","unstructured":"Chancharoenthana W, Leelahavanichkul A, Wattanatorn S, Avihingsanon Y, Praditpornsilpa K, Eiam-Ong S, Townamchai N (2018) Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation. PLoS One 13:e0209708","journal-title":"PLoS One"},{"key":"7433_CR90","unstructured":"Hogan J (2024) Non-Invasive Monitoring of Pediatric Kidney Transplant Recipients and Immunosuppression Personalization: an Open-labeled Multicenter Randomized Controlled Study (MONITOR). ClinicalTrails.gov. Identifier: NCT06761482. https:\/\/clinicaltrials.gov\/study\/NCT06761482?tab=study"},{"key":"7433_CR91","doi-asserted-by":"crossref","unstructured":"Martial LC, Hoogtanders KEJ, Schreuder MF, Cornelissen EA, van der Heijden\u00a0J, Joore MA, Van Maarseveen EM, Burger DM, Croes S, Bruggemann RJM,\u00a0Aarnoutse RE (2017) Dried blood spot sampling for tacrolimus and\u00a0mycophenolic acid in children: analytical and clinical validation. Ther Drug\u00a0Monit 39:412\u2013421","DOI":"10.1097\/FTD.0000000000000422"},{"key":"7433_CR92","doi-asserted-by":"publisher","DOI":"10.1111\/petr.12983","volume":"21","author":"A Al-Uzri","year":"2017","unstructured":"Al-Uzri A, Freeman KA, Wade J, Clark K, Bleyle LA, Munar M, Koop DR (2017) Longitudinal study on the use of dried blood spots for home monitoring in children after kidney transplantation. Pediatr Transplant 21:e12983","journal-title":"Pediatr Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07433-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:03:53Z","timestamp":1784059433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07433-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":92,"alternative-id":["7433"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07433-0","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"EAMC, AHMB, FHMP, and HdJ are members of the Kidnie consortium, supported by the Dutch Kidney Foundation (Nierstichting). TAG, GN, MB, FE, AD, EAMC, AHMB, LP, LTW, and HdJ were members of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften; AWMF) guideline development group on immunosuppression in children.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}